Fisher & Paykel Healthcare Corporation Limited today announced that Chief Financial Officer, Tony Barclay, will retire at the end of May 2018. Tony will continue to support the company in a consulting role over the following 12 months.
“Having made a huge contribution to the growth of Fisher & Paykel Healthcare over the past 22 years, Tony has decided to step away from his role to allow him to have more time for family, personal travel and consider areas of future interest,” said Managing Director & CEO Lewis Gradon.
“We would like to thank Tony for the dedication he has shown and his commitment to the company throughout his time with Fisher & Paykel Healthcare,” said Mr Gradon.
“It has been a privilege to have been part of an exceptional team for the past 22 years. I have enjoyed my time immensely and am extremely proud of what we have achieved as a company. The company’s ongoing opportunities for growth are very exciting and I look forward to seeing many of those opportunities come to fruition. I would particularly like to thank the people who I have worked with for their support and friendship and also the investor/analyst community for the enjoyable interactions we have had over the years. In terms of my own future, I am looking forward to spending more time with my family and then considering areas of future interest,” said Mr Barclay.
The company is pleased to announce that Andrea Blackie, GM Finance has been appointed to the role of Acting Chief Financial Officer with effect from 1 June 2018.
Ms Blackie has been with Fisher & Paykel Healthcare since January 2017 in the role of General Manager Finance. Prior to joining the company, Andrea was an Executive Director within PwC Assurance New Zealand. She has over 15 years’ experience in New Zealand and the United Kingdom working with a number of listed global manufacturing and technology businesses.
“The company has commenced a formal process to appoint Tony’s successor and we will update the market in due course. We thank Tony for all of his many years’ of loyal service and commitment, and wish him all the very best. He will be greatly missed and difficult to replace,” concluded Mr Gradon.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website
www.fphcare.com.
Ends
Contact:
Investors:
Marcus Driller
General Manager Corporate
marcus.driller@fphcare.co.nz
+64 (0) 27 578 9663
Media:
Rachel Reynolds
Senior Communications Manager
rachel.reynolds@fphcare.co.nz
+64 (0) 21 713 911
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact